Listed Company Roadshow

Agendas
9:00 - 12:05
  • 上市公司路演专场
  • Listed Company Roadshow
    • Moderator
  • 孙帅 ， 花旗中国商业银行医药行业主管
  • William SUN , Healthcare Industry Head, Citi China Commercial Banking
9:00 - 9:05
  • 开场致辞
  • Opening Remarks
  • 孙帅 花旗中国商业银行医药行业主管
  • William SUN , Healthcare Industry Head, Citi China Commercial Banking
9:05 - 9:25
  • 项目1
  • Project 1
  • 博安生物：厚积“博”发，创新引领未来
  • Boan Biotech：Building on a Solid Past, Innovating for a Winning Future
  • 姜华 山东博安生物技术股份有限公司董事长兼CEO
  • Sammy JIANG , Chairlady & CEO of Shandong BoAn Biotechnology Co., Ltd.
9:25 - 9:45
  • 项目2
  • Project 2
  • 基石药业管线进展及出海之路
  • Cstone's Pipeline Progress and Globalization
  • 杨建新 基石药业（苏州）有限公司首席执行官兼研发总裁、执行董事
  • Jason YANG , CEO & President of R&D, Executive Director of the Board,CStone Pharmaceuticals
9:45 - 10:05
  • 项目3
  • Project 3
  • 抗HIV长效疗法与慢病新药研发
  • Development of Long-Acting Antiretroviral Therapies and New Drugs for Chronic Diseases
  • 谢东 前沿生物药业（南京）股份有限公司董事长、首席科学家
  • XIE Dong , Chairman of the Board & CSO, Frontier Biotechnologies Inc.
10:05 - 10:25
  • 项目4
  • Project 4
  • 诺诚健华医药有限公司项目进展
  • InnoCare Pharma Limited Business Update
  • 傅欣 诺诚健华医药有限公司首席财务官
  • FU Xin , CFO of InnoCare Pharma Limited
10:25 - 10:45
  • 项目5
  • Project 5
  • “千鼠万抗”全人抗体库，加速创新疗法开发
  • Off-the-Shelf Fully Human Antibodies from "RenBiologics" Accelerate the Development of Innovative Therapeutics
  • 郭朝设 百奥赛图（北京）医药科技股份有限公司副总经理、全球商务负责人
  • GUO Chaoshe , Vice President and Global BD Head of Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
10:45 - 11:05
  • 项目6
  • Project 6
  • 推动产品全球上市及产品管线持续进展
  • Advancing to Global Launches & Continued Pipeline Progress
  • 吴嘉俊 和黄医药投资者关系和资本战略副总裁
  • David Ng , Vice President & Head of Investor Relations and Capital Strategy, HUMTHMED
11:05 - 11:25
  • 项目7
  • Project 7
  • 百济神州：具有竞争优势的新一代肿瘤学创新者
  • BeiGene, A Competitively Advantaged, Next-Gen Oncology Innovator
  • 沈志荣 百济神州副总裁、全球转化研究及转化医学负责人
  • SHEN Zhirong , Vice President, Global Head of Translational Discovery, Research and Medicine, BeiGene
11:25 - 11:45
  • 项目8
  • Project 8
  • 为患者创新，全球领先治疗
  • Patient-Centric Innovation Global Cutting-Edge Therapies
  • 温定宙 亚盛医药投资者关系及战略负责人
  • Hogan Wan , Head of IR and Strategy, Ascentage Pharma
11:45 - 12:05
  • 项目9
  • Project 9
  • 新型HBV核衣壳组装调节剂的临床前研究
  • Preclinical Studies of a Novel Hbv Capsid Assembly Modulator
  • 山松 深圳微芯生物科技股份有限公司早期研发中心主任
  • SHAN Song , Head of Early Discovery and Development, Shenzhen Chipscreen Biosciences Co., Ltd.